Literature DB >> 1841757

Familial risk factors for prostate cancer.

B S Carter1, G D Steinberg, T H Beaty, B Childs, P C Walsh.   

Abstract

This chapter describes the application of the genetic epidemiological approach to the study of human prostate cancer. We review the evidence for the familial clustering of prostate cancer and the Mendelian nature of this aggregation. The nature of this clustering is such that the closer genetically a man is to an affected relative and the greater number of relatives affected in a man's family, the greater his risk of prostate cancer. A complex segregation analysis of the 691 prostate cancer families showed that prostate cancer clustering can be explained by Mendelian inheritance of a rare autosomal gene producing prostate cancer at an early age. A model of inherited prostate cancer in the setting of multistep carcinogenesis is presented. The implications of these data for clinicians who diagnose and treat prostate cancer are also discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1841757

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  7 in total

1.  Detection of prostate cancer. Recent evidence suggests screening may be justified in high risk younger men.

Authors:  W Foulkes
Journal:  BMJ       Date:  1995-04-29

2.  Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans.

Authors:  Kristin Gunderson; Christopher Y Wang; Ruoxiang Wang
Journal:  Cancer Epidemiol       Date:  2010-12-16       Impact factor: 2.984

3.  [Histopathology reports of findings of prostate needle biopsies. Individual treatment].

Authors:  I Damjanoski; J Müller; T J Schnöller; R Küfer; L Rinnab
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

4.  Prostate cancer risk-associated genetic markers and their potential clinical utility.

Authors:  Jianfeng Xu; Jielin Sun; S Lilly Zheng
Journal:  Asian J Androl       Date:  2013-04-08       Impact factor: 3.285

5.  Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91.

Authors:  M McCredie; G J Macfarlane; J Stewart; M Coates
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

Review 6.  Prostate cancer genomics.

Authors:  P E Li; P S Nelson
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

7.  Incidental prostate cancer at the time of cystectomy: the incidence and clinicopathological features in Chinese patients.

Authors:  Jiahua Pan; Wei Xue; Jianjun Sha; Hu Yang; Fan Xu; Hanqing Xuan; Dong Li; Yiran Huang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.